Overview

Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)

Status:
Completed

Trial end date:
2009-03-01

Target enrollment:

Participant gender:

Summary

The study aim is to evaluate the influence of the anti-T-lymphocyte globulin ATG-Fresenius S given pre-transplant in addition to standard GvHD prophylaxis with cyclosporine A and a short course of methotrexate with respect to efficacy and safety.

Phase:

Phase 3

Details

Lead Sponsor:

Neovii Biotech

Collaborator:

University Medical Center Freiburg

Treatments:

Cyclosporine
Cyclosporins
Methotrexate